TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7526006

Group type: EXPERIMENTAL
Intervention: Urolase right angle firing neodymium:YAG laser fiber
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard transurethral electroresection of the prostate
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 25
Study: 2682160

Group type: EXPERIMENTAL
Intervention: Hyposensitization treatment
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 4601308

Group type: EXPERIMENTAL
Intervention: iv inosine, pyruvate, and inorganic phosphate (IPP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: iv saline
Number of subjects: 10
Study: 29911503

Group type: EXPERIMENTAL
Intervention: Audience response systems
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (standard methods)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 26775599

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist intervention focusing on medication compliance, smoking cessation, exercise, inhaler use, and follow-up.
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group (CG) without pharmacist intervention.
Number of subjects: 260
Study: 24314853

Group type: EXPERIMENTAL
Intervention: Recombinant human EPO (rhEPO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no rhEPO)
Number of subjects: 20
Study: 22641932

Group type: EXPERIMENTAL
Intervention: Direct contact person-to-person prayer intervention (six weekly 1-hour sessions)
Number of subjects: 44
Study: 20394720

Group type: EXPERIMENTAL
Intervention: Low-dose recombinant human interferon alpha-2b nasal spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 18550981

Group type: EXPERIMENTAL
Intervention: Remote stimulation (RS) group performed a 10-minute surface electrical stimulation program on the rectus femoris of the non-dominant leg (frequency 100 Hz, impulse 300 micros, 10 seconds on/10 seconds off).
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CTL) relaxed for 10 minutes without performing any training.
Number of subjects: 36
Study: 15855073

Group type: EXPERIMENTAL
Intervention: Patient education program including A Pregnant Woman's Guide to Stop Smoking, a companion video, clinic reinforcement, and patient-centered counseling.
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Focus groups with nurses and social workers providing the intervention.
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Individual interviews with women who received the intervention.
Number of subjects: 265
Study: 11719835

Group type: EXPERIMENTAL
Intervention: Pamidronate (90 mg single infusion)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 39
Study: 9386675

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine administered at 3 days of age (n = 25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine administered at 1 month of age (n = 25)
Number of subjects: 50
Study: 7898093

Group type: EXPERIMENTAL
Intervention: Weight reduction and physical exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium-channel blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockers and centrally acting drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 0
Study: 3298559

Group type: EXPERIMENTAL
Intervention: Mitoxantrone combined with vincristine and prednisolone (VMP)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Doxorubicin combined with vincristine and prednisolone (VAP)
Number of subjects: 115
Study: 2754147

Group type: EXPERIMENTAL
Intervention: Maternal avoidance of cow's milk, egg, and peanut during the third trimester of pregnancy and lactation; infant use of casein hydrolysate (Nutramigen) for supplementation or weaning, avoidance of solid foods for 6 months; cow's milk, corn, soy, citrus, and wheat for 12 months; egg, peanut, and fish for 24 months
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Maternal avoidance of allergenic foods and infant dietary restrictions
Number of subjects: 288

Group type: COMPARATOR
Intervention: Control group with unrestricted diets and following American Academy of Pediatrics feeding guidelines
Number of subjects: 288
Study: 30874886

Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 664

Group type: COMPARATOR
Intervention: No telemonitoring
Number of subjects: 664
Study: 28882136

Group type: EXPERIMENTAL
Intervention: Preparatory information for children undergoing general anaesthesia
Number of subjects: 0
Study: 25416738

Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to daily Occupational Performance (CO‐OP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 35
Study: 23607998

Group type: EXPERIMENTAL
Intervention: Viewing neutral pictures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viewing pleasant pictures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viewing unpleasant pictures
Number of subjects: 0
Study: 21742094

Group type: EXPERIMENTAL
Intervention: Pexelizumab
Number of subjects: 5745

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 5745
Study: 19783767

Group type: EXPERIMENTAL
Intervention: Humalog KwikPen
Number of subjects: 232

Group type: COMPARATOR
Intervention: Vial and Syringe
Number of subjects: 232

Group type: COMPARATOR
Intervention: FlexPen
Number of subjects: 232
Study: 16757759

Group type: EXPERIMENTAL
Intervention: rhBMP-2 (1.50 mg/mL)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Control (intramedullary nail fixation and routine soft-tissue management)
Number of subjects: 510
Study: 15251269

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous alcohol infusion
Number of subjects: 24
Study: 11845484

Group type: EXPERIMENTAL
Intervention: Intensive home follow-up program
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (traditional cardiac rehabilitation)
Number of subjects: 62
Study: 9766723

Group type: EXPERIMENTAL
Intervention: Lumbar spine MRI
Number of subjects: 72

Group type: COMPARATOR
Intervention: Surgery (including spinal fusion)
Number of subjects: 72
Study: 7828202

Group type: EXPERIMENTAL
Intervention: Treated group (29 patients) - splint therapy, physical therapy, counseling, NSAID medications
Number of subjects: 49

Group type: COMPARATOR
Intervention: Untreated group (20 patients)
Number of subjects: 49
Study: 3352467

Group type: EXPERIMENTAL
Intervention: A mixture containing a fixed proportion of seven essential amino acids (L‐isoleucine 11.5%, L‐leucine 18.0%, L‐lysine 13.1%, L‐methionine 18.0%, L‐phenylalanine 18.0%, L‐threonine 8.2%, L‐valine 13.1%)
Number of subjects: 0
Study: 30762141

Group type: EXPERIMENTAL
Intervention: 30 min of patient-preferred live music (n=47)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: 30 min of patient-preferred pre-recorded music (n=47)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard care (n=49)
Number of subjects: 143
Study: 28777195

Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin I (Abbott ARCHITECT) measured within 24 hours of intubation
Number of subjects: 1057

Group type: EXPERIMENTAL
Intervention: Adjustment for Sequential Organ Failure Assessment score
Number of subjects: 1057
Study: 25873254

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program for secondary falls prevention
Number of subjects: 344

Group type: COMPARATOR
Intervention: Control group (usual behavior prior to study enrolment)
Number of subjects: 344
Study: 23406861

Group type: EXPERIMENTAL
Intervention: Protection mechanical ventilation (group P)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (group C)
Number of subjects: 60
Study: 22211209

Group type: EXPERIMENTAL
Intervention: Enhanced mental health intervention (family-based cognitive-behavioral therapy session + care linkage telephone contacts)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Enhanced mental health intervention
Number of subjects: 181

Group type: COMPARATOR
Intervention: Usual emergency department care enhanced by provider education
Number of subjects: 181
Study: 19147485

Group type: EXPERIMENTAL
Intervention: Pharmacological cardioversion with anti-arrhythmic drugs for 4 weeks
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Electrical cardioversion
Number of subjects: 102

Group type: COMPARATOR
Intervention: Refractory AF (RAF) group
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Duration of AF >5 months
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: MMP-2 >767.0 ng/mL
Number of subjects: 102
Study: 16477828

Group type: EXPERIMENTAL
Intervention: Monocular left observation condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monocular right observation condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Binocular observation condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upper and lower boundaries of probability summation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Binocular capacity coefficient
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 0
Study: 15026584

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 19
Study: 11403809

Group type: EXPERIMENTAL
Intervention: Antibiotics (clarithromycin 500 mg and amoxicillin 1000 mg twice daily) for 10 days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo for 10 days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (H pylori-negative)
Number of subjects: 70
Study: 9137510

Group type: EXPERIMENTAL
Intervention: Vinorelbine (VNB) weekly IV bolus of 30 mg/m (14 patients)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vinorelbine (VNB) continuous infusion (CI) schedule of 8 mg IV bolus on day 1 followed by 8 mg/m2/die CI day 1 to 4, q 21 days (16 patients)
Number of subjects: 30
Study: 12959289

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diflunisal
Number of subjects: 0
Study: 3501162

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (AP; dipyridamole 400 mg + aspirin 50 mg/day)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Anticoagulation (AC)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (AP)
Number of subjects: 251
Study: 28985369

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including access to online modules and a face-to-face educational session.
Number of subjects: 528

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 528
Study: 26651598

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (10 Hz, 120% motor threshold, 3000 pulses/session, up to 30 sessions)
Number of subjects: 10
Study: 25066140

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone plus melatonin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Melatonin only
Number of subjects: 60
Study: 22353992

Group type: EXPERIMENTAL
Intervention: Infraspinatus test (IsT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Nerve conduction velocity (NCV)
Number of subjects: 34
Study: 20461319

Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD) 20‐mg capsules twice a day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo twice a day
Number of subjects: 20
Study: 17593515

Group type: EXPERIMENTAL
Intervention: steroid/Aza
Number of subjects: 475

Group type: COMPARATOR
Intervention: steroid/CsA
Number of subjects: 475
Study: 16193479

Group type: EXPERIMENTAL
Intervention: Expressive writing plus brief office intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Brief office intervention only
Number of subjects: 60
Study: 12173200

Group type: EXPERIMENTAL
Intervention: Droperidol 0.625 mg i.v.
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 120
Study: 10441094

Group type: EXPERIMENTAL
Intervention: Lepirudin treatment (0.4 mg/kg IV bolus, followed by 0.15 mg/kg/h intravenous infusion), n=65
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Lepirudin treatment in conjunction with thrombolysis (0.2 mg/kg, followed by 0.10 mg/kg/h), n=4
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Lepirudin prophylaxis (0.10 mg/kg/h), n=43
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Lepirudin-treated patients
Number of subjects: 112

Group type: COMPARATOR
Intervention: Historical control patients
Number of subjects: 112
Study: 8588062

Group type: EXPERIMENTAL
Intervention: Serotonin reuptake inhibitors over an 8-week period
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serotonin reuptake inhibitors
Number of subjects: 0
Study: 2222943

Group type: EXPERIMENTAL
Intervention: Intravenous captopril (1 to 10 mg delivered at 10 min intervals over 50 to 80 min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous captopril (incremental doses up to 40 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous captopril
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous captopril with hydrochlorothiazide
Number of subjects: 24
Study: 215097

Group type: EXPERIMENTAL
Intervention: Piribedil
Number of subjects: 11
Study: 31755967

Group type: EXPERIMENTAL
Intervention: Intravitreal Ziv-Aflibercept 1.25 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Intravitreal Bevacizumab
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Intravitreal Ziv-Aflibercept 2.5 mg
Number of subjects: 123
Study: 27918764

Group type: EXPERIMENTAL
Intervention: mFOLFOX6 plus onartuzumab (10 mg/kg)
Number of subjects: 562

Group type: COMPARATOR
Intervention: mFOLFOX6 plus placebo
Number of subjects: 562
Study: 27465372

Group type: EXPERIMENTAL
Intervention: 10 g fiber from SCF/d
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 20 g fiber from SCF/d
Number of subjects: 14

Group type: COMPARATOR
Intervention: 0 g fiber from SCF/d
Number of subjects: 14
Study: 24586534

Group type: EXPERIMENTAL
Intervention: Daily vaginal gel and oral tablet regimens (PrEP)
Number of subjects: 102
Study: 23096142

Group type: EXPERIMENTAL
Intervention: Stimulation therapy with drifting sinus gratings (n=8), performed 5 times a week over 4 weeks, 2×20 min sessions, combined with computer games
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group with only computer games with a neutral background (n=7)
Number of subjects: 15
Study: 20103069

Group type: EXPERIMENTAL
Intervention: Laparoscopic skill training protocol with proficiency targets
Number of subjects: 14

Group type: COMPARATOR
Intervention: Laparoscopic skill training protocol without proficiency targets
Number of subjects: 14
Study: 18575077

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/day
Number of subjects: 25620

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg/day
Number of subjects: 25620

Group type: EXPERIMENTAL
Intervention: Combination of telmisartan and ramipril
Number of subjects: 25620

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25620
Study: 15953937

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sit-up exercise
Number of subjects: 54
Study: 11832851

Group type: EXPERIMENTAL
Intervention: Tension-free mesh repair (n=175)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Non-mesh modified Bassini's repair (n=164)
Number of subjects: 299
Study: 10398312

Group type: EXPERIMENTAL
Intervention: Zinc acetate (50 to 75 mg of elemental zinc orally daily) for 3 years after 1 year observation in Gr A.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo for 1 year followed by zinc supplementation (50 to 75 mg of elemental zinc orally daily) for 2 years in Gr B.
Number of subjects: 32

Group type: COMPARATOR
Intervention: No intervention in Gr C (zinc sufficient).
Number of subjects: 32
Study: 8523654

Group type: EXPERIMENTAL
Intervention: PGE1 (0.02‐0.05 micrograms.kg‐1.min‐1 administered intravenously throughout the operation)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no PGE1 administration)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: PGE1
Number of subjects: 16
Study: 1453605

Group type: COMPARATOR
Intervention: Low hydration (LowH)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High hydration (HighH)
Number of subjects: 10
Study: 2578610

Group type: EXPERIMENTAL
Intervention: Therapeutic peritoneal lavage (2 liters per hour for three days)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (full supportive treatment only)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Therapeutic peritoneal lavage
Number of subjects: 91
Study: 30739747

Group type: EXPERIMENTAL
Intervention: MISTIE treatment (1·0 mg alteplase every 8 h for up to nine doses)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: MISTIE treatment
Number of subjects: 506
Study: 30103205

Group type: EXPERIMENTAL
Intervention: In Favour of Myself (after-school setting)
Number of subjects: 224

Group type: COMPARATOR
Intervention: In Favour of Myself (school-based setting)
Number of subjects: 224
Study: 26085198

Group type: EXPERIMENTAL
Intervention: Intelligence seven needle therapy
Number of subjects: 64
Study: 24988965

Group type: EXPERIMENTAL
Intervention: Melatonin (melaxen)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study: 24190686

Group type: EXPERIMENTAL
Intervention: Intensive intervention (counseling sessions, distribution of tailored educational brochures, demonstration of home air pollution, and 2 follow-up counseling telephone calls)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Intensive intervention
Number of subjects: 250

Group type: COMPARATOR
Intervention: Minimal intervention (distribution of standard leaflets)
Number of subjects: 250
Study: 21414953

Group type: EXPERIMENTAL
Intervention: Baclofen 10 mg t.i.d.
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Baclofen 20 mg t.i.d.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 19051221

Group type: EXPERIMENTAL
Intervention: Ile/Ile genotype of GST-P1
Number of subjects: 209

Group type: COMPARATOR
Intervention: Ile/Val + Val/Val genotypes
Number of subjects: 209
Study: 17580458

Group type: EXPERIMENTAL
Intervention: Ceramic A (Initial, GC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ceramic B (Triceram, Esprident)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ceramic C (Cercon Ceram S, DeguDent)
Number of subjects: 6
Study: 14709454

Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron intravenously (high-risk group)
Number of subjects: 162

Group type: COMPARATOR
Intervention: No prophylaxis (low-risk group)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Overall institutional PONV incidence
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Treatment with ondansetron (both groups)
Number of subjects: 162
Study: 11211889

Group type: EXPERIMENTAL
Intervention: Interferon alpha-2b + ribavirin (IFN + RIBA)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Interferon alpha-2b + amantadine (IFN + AMANT)
Number of subjects: 118
Study: 9737826

Group type: EXPERIMENTAL
Intervention: Famciclovir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 7586929

Group type: EXPERIMENTAL
Intervention: Felbamate 2400 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2252164

Group type: EXPERIMENTAL
Intervention: High potency (HP) extract (300 micrograms AgE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low potency (LP) extracts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High potency (HP) extract (9-dose regimen)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low potency (LP) extract
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High potency (HP) extract
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High potency (HP) and Low potency (LP) extracts
Number of subjects: 0
Study: 6118758

Group type: EXPERIMENTAL
Intervention: dl‐propranolol (640 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: d‐propranolol (640 mg/day)
Number of subjects: 0
Study: 30785645

Group type: EXPERIMENTAL
Intervention: Cannulation by trainees in patients with common bile duct stone (CBDS)
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Cannulation by trainees in patients with biliary stricture (BS)
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Cannulation by trainees in patients with other indications
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Presence of type A diverticulum
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Indication of biliary stricture (BS)
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Biliary infection in BS vs CBDS
Number of subjects: 1044
Study: 28187138

Group type: EXPERIMENTAL
Intervention: Gaze training intervention (QET)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Technical training (TT)
Number of subjects: 21
Study: 26329472

Group type: EXPERIMENTAL
Intervention: Peer-led healthy lifestyle intervention (derived from the Group Lifestyle Balanced Program, lasting 12 months, delivered by trained peer specialists)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 24187119

Group type: EXPERIMENTAL
Intervention: Community doula home visiting intervention
Number of subjects: 248
Study: 20652630

Group type: EXPERIMENTAL
Intervention: Two-session HIV/HCV counseling and education (C&E) model added to treatment as usual (TAU)
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: One-session therapeutic alliance (TA) intervention conducted by outpatient counselors to facilitate treatment entry plus TAU
Number of subjects: 632

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 632
Study: 19649583

Group type: EXPERIMENTAL
Intervention: 1,5-pentanediol (PD) gel
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 105
Study: 17370492

Group type: EXPERIMENTAL
Intervention: Triple puncture at Tianzong (SI 11) combined with local points of the elbow
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine acupuncture (local points of the elbow)
Number of subjects: 62
Study: 15508669

Group type: EXPERIMENTAL
Intervention: Video-trained participants using the Philips FR2
Number of subjects: 256

Group type: COMPARATOR
Intervention: Naive participants using the Philips FR2
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Video-trained participants using the HS1
Number of subjects: 256

Group type: COMPARATOR
Intervention: Naive participants using the HS1
Number of subjects: 256